Basit öğe kaydını göster

dc.contributor.authorTemiz, Can
dc.contributor.authorKalemci, Serdar
dc.contributor.authorMicili, Serap Cilaker
dc.contributor.authorTekmen, Isil
dc.contributor.authorYildiz, Gulserap
dc.contributor.authorAcar, Tolgahan
dc.contributor.authorAkkoclu, Atila
dc.date.accessioned2020-11-20T15:05:29Z
dc.date.available2020-11-20T15:05:29Z
dc.date.issued2015
dc.identifier.issn0030-9982
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3021
dc.descriptionTEKMEN, ISIL/0000-0003-0521-2654en_US
dc.descriptionWOS: 000360441800012en_US
dc.descriptionPubMed ID: 26060161en_US
dc.description.abstractObjective: To determine the effects of methyl palmitate on murine model of chronic asthma. Methods: The experimental study was conducted in the animal laboratory of DokuzEylul University, Turkey, from October to December, 2012, and comprised BALB/c mice whowere divided into four equal groups: three experimental and one control group. All groups except the control group were sensitised and challenged with ovalbumin. Mice with experimentally-induced asthma in Group I received saline; Group II dexamethasone 1mg/kg; Group III methyl palmitate300mg/kg intraperitoneally three times per week in the last four weeks of the study period. Animals were sacrificed 24h after the last administration of study drugs. Histological findings of airways were evaluated by light microscopic examination. Blood samples from vena cava inferior were taken for measurement of interleukin-5 levels. SPSS 15 was used for statistical analysis. Results: The 28 female mice in the study were divided into 4 groups of 7(25%) each. The age range of the animals was 6-8weeks, and the weight range was 18-20g. All histological parameters and interleukin-5 levels of asthma in the Group III were significantly ameliorated compared to the Group I (p<0.05)). All histological parameters and interleukin-5 levels were similar between Group III and Group II. Conclusion: Methyl palmitate exhibited anti-inflammatory effects by resolving the histological changes and reducing the interleukin-5 levels in murine model of chronic asthma.en_US
dc.item-language.isoengen_US
dc.publisherPakistan Medical Assocen_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-Inflammatoryen_US
dc.subjectChronic Asthmaen_US
dc.subjectMouseen_US
dc.subjectInterleukin-5en_US
dc.subjectMethyl Palmitateen_US
dc.subjectAirway Remodelingen_US
dc.titleThe effect of methyl palmitate on treatment of experimental asthmaen_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTemp[Temiz, Can; Akkoclu, Atila] Dokuz Eylul Univ, Fac Med, Dept Chest Dis, Izmir, Turkey -- [Micili, Serap Cilaker; Tekmen, Isil] Dokuz Eylul Univ, Fac Med, Dept Histol, Izmir, Turkey -- [Yilmaz, Osman] Dokuz Eylul Univ, Fac Med, Multidisciplinary Lab, Izmir, Turkey -- [Kalemci, Serdar] Mugla Univ, Fac Med, Dept Chest Dis, Mugla, Turkey -- [Yildiz, Gulserap] Adnan Menderes Univ, Hlth Sci Inst, Dept Biochem, Aydin, Turkey -- [Acar, Tolgahan] Sifa Univ, Fac Med, Dept Anat, Izmir, Turkeyen_US
dc.identifier.volume65en_US
dc.identifier.issue6en_US
dc.identifier.startpage632en_US
dc.identifier.endpage636en_US
dc.relation.journalJournal of the Pakistan Medical Associationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster